These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 28374413

  • 1. Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.
    Gómez-Hurtado N, Domínguez-Rodríguez A, Mateo P, Fernández-Velasco M, Val-Blasco A, Aizpún R, Sabourin J, Gómez AM, Benitah JP, Delgado C.
    J Physiol; 2017 Jul 01; 595(13):4227-4243. PubMed ID: 28374413
    [Abstract] [Full Text] [Related]

  • 2. Prolonged leptin treatment increases transient outward K⁺ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes.
    Gómez-Hurtado N, Fernández-Velasco M, Fernández-Alfonso MS, Boscá L, Delgado C.
    Pflugers Arch; 2014 May 01; 466(5):903-14. PubMed ID: 24046152
    [Abstract] [Full Text] [Related]

  • 3. Ca2+/calmodulin-dependent protein kinase II is essential in hyperacute pressure overload.
    Baier MJ, Klatt S, Hammer KP, Maier LS, Rokita AG.
    J Mol Cell Cardiol; 2020 Jan 01; 138():212-221. PubMed ID: 31836540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart.
    Zhao Z, Babu GJ, Wen H, Fefelova N, Gordan R, Sui X, Yan L, Vatner DE, Vatner SF, Xie LH.
    Am J Physiol Heart Circ Physiol; 2015 Feb 01; 308(3):H240-9. PubMed ID: 25485900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of human Kv4.3/KChIP2 channel inactivation kinetics by cytoplasmic Ca2.
    Groen C, Bähring R.
    Pflugers Arch; 2017 Nov 01; 469(11):1457-1470. PubMed ID: 28735419
    [Abstract] [Full Text] [Related]

  • 11. Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.
    Kato T, Yamamoto T, Nakamura Y, Nanno T, Fukui G, Sufu Y, Hamada Y, Maeda T, Nishimura S, Ishiguchi H, Murakami W, Fukuda M, Xu X, Hino A, Ono M, Oda T, Okuda S, Kobayashi S, Koseki N, Kyushiki H, Yano M.
    Heart Rhythm; 2017 Jan 01; 14(1):120-127. PubMed ID: 27771553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes.
    Mustroph J, Wagemann O, Lücht CM, Trum M, Hammer KP, Sag CM, Lebek S, Tarnowski D, Reinders J, Perbellini F, Terracciano C, Schmid C, Schopka S, Hilker M, Zausig Y, Pabel S, Sossalla ST, Schweda F, Maier LS, Wagner S.
    ESC Heart Fail; 2018 Aug 01; 5(4):642-648. PubMed ID: 30117720
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.
    Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K, Dimaano VL, Abraham TP, O'Rourke B, Akar FG, Kass DA, Tomaselli GF.
    Circulation; 2009 Mar 10; 119(9):1220-30. PubMed ID: 19237662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.